AGP Picks
View all

Carrier screening market seen reaching $6.57B by 2030

Nov. 10, 2026
Carrier screening market seen reaching $6.57B by 2030
By AI, Created 16:15 UTC, Nov 10, 2026, AGP -

The carrier screening market is projected to nearly double from 2025 to 2030 as genetic testing expands and preventive reproductive care gains traction. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Carrier screening is becoming a bigger part of prenatal and preconception care as families and clinicians look to identify inherited disease risks earlier. - The market’s growth reflects broader demand for personalized medicine, preventive healthcare and expanded access to genetic counseling.

What happened: - The Business Research Company’s Carrier Screening Global Market Report 2026 says the market rose from $3.16 billion in 2025 to $3.68 billion in 2026. - The report projects the market will reach $6.57 billion by 2030. - The report links the 2025-2026 increase to a 16.3% compound annual growth rate. - It forecasts a 15.7% CAGR through 2030. - The company posted a free sample of the report.

The details: - Carrier screening is a genetic test that identifies people who carry one copy of a gene mutation that can cause a hereditary disease if inherited in two copies. - The testing helps assess genetic risk for couples planning to have children. - The market’s recent growth has been driven by greater awareness of genetic disorders. - Wider availability of prenatal and preconception testing has also supported growth. - Advances in DNA sequencing have improved testing capabilities. - Broader use of laboratory diagnostics and better access to genetic counseling have added momentum. - The report says future growth will be supported by demand for personalized medicine. - It also points to more investment in genomics research, expanded population-wide screening programs, more AI-driven genomic analytics and a stronger focus on preventive healthcare. - The report highlights broader use of expanded carrier screening panels, increased use of next-generation sequencing, deeper AI integration in genetic interpretation and more reproductive health screening. - The report says an older population is another growth driver, including people choosing to conceive later in life. - In October 2025, the UK Office for National Statistics said the number of people aged 90 and above reached 625,000 in 2024, up 2.2% from 612,000 the year before. - The company also published the full carrier screening market report.

Between the lines: - The market outlook suggests genetic testing is moving from a niche diagnostic tool toward a more routine part of reproductive planning. - AI and next-generation sequencing are likely to reshape how genetic risk data is processed and delivered, which could widen adoption if costs and access improve. - North America’s lead suggests a mature healthcare and diagnostics market, while faster growth in Asia-Pacific points to broader global catch-up.

What's next: - The report expects North America to remain the largest regional market in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables. - The Business Research Company listed contact details for expert inquiries, including Saumya Sahay and the company’s marketing email.

The bottom line: - Carrier screening is set for steady, double-digit growth as genetic testing becomes more central to preventive and reproductive healthcare.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Post Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.